FOLD - Amicus Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

FOLD is currently covered by 5 analysts with an average price target of $15.5. This is a potential upside of $5.57 (56.09%) from yesterday's end of day stock price of $9.93.

Amicus Therapeutics's activity chart (see below) currently has 156 price targets and 104 ratings on display. The stock rating distribution of FOLD is 83.33% BUY and 16.67% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 47.96% with an average time for these price targets to be met of 353.33 days.

Highest price target for FOLD is $21, Lowest price target is $9, average price target is $15.

Most recent stock forecast was given by GIL BLUM from NEEDHAM on 18-Sep-2025. First documented stock forecast 20-Aug-2014.

Currently out of the existing stock ratings of FOLD, 5 are a BUY (83.33%), 1 are a HOLD (16.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$14

$4.07 (40.99%)

2 months 12 days ago
(18-Sep-2025)

0/1 (0%)

$5.52 (65.09%)

Buy

$12

4 months 13 days ago
(17-Jul-2025)

0/4 (0%)

$2.64 (28.21%)

Hold

$9

$-0.93 (-9.37%)

$14

6 months 28 days ago
(02-May-2025)

5/6 (83.33%)

$2.33 (34.93%)

168

Buy

$16

$6.07 (61.13%)

$17

9 months 2 days ago
(28-Feb-2025)

6/16 (37.5%)

$6.51 (68.60%)

454

Buy

$21

$11.07 (111.48%)

$21

10 months 15 days ago
(15-Jan-2025)

0/7 (0%)

$11.73 (126.54%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FOLD (Amicus Therapeutics) average time for price targets to be met?

On average it took 353.33 days on average for the stock forecasts to be realized with a an average price target met ratio 47.96

Which analyst has the current highest performing score on FOLD (Amicus Therapeutics) with a proven track record?

DEBJIT CHATTOPADHYAY

Which analyst has the most public recommendations on FOLD (Amicus Therapeutics)?

Debjit Chattopadhyay works at GUGGENHEIM and has 3 price targets and 2 ratings on FOLD

Which analyst is the currently most bullish on FOLD (Amicus Therapeutics)?

Michael Ulz with highest potential upside - $15.07

Which analyst is the currently most reserved on FOLD (Amicus Therapeutics)?

Salveen Richter with lowest potential downside - -$0.93

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?